PRP Effectiveness and Evidence Quality: What Patients Should Understand Before a Consultation

The short answer

There is no single yes-or-no answer to whether platelet-rich plasma (PRP) works, and the honest summary is that the quality of the evidence varies by condition, by how PRP is prepared, and by how long researchers follow patients. The most recent pooled research on knee osteoarthritis — a 2025 systematic review and meta-analysis of 11 randomized controlled trials involving 1,616 participants — found that pooled pain scores favored PRP over saline placebo at three and six months, but the results were highly heterogeneous, and the review found no efficacy at twelve months. Function favored PRP at three months but not at six or twelve months. The authors described the evidence as showing weak efficacy up to six months and said the clinical relevance remains debatable.^[PubMed]

That is a useful starting point for a patient because it shows both what the research suggests and where it stops short. It does not mean PRP is proven for every joint, tendon, or ligament, and it does not mean PRP is ineffective everywhere. It means the strongest recent pooled evidence supports a cautious, time-limited, condition-specific reading rather than a broad promise. The rest of this article explains how to interpret that evidence and what to ask before a consultation.

What the evidence supports

The 2025 knee osteoarthritis review is the clearest recent example of how PRP evidence is measured. It compared intra-articular PRP with saline placebo and reported outcomes at three, six, and twelve months. The pattern — a possible early-to-mid-term benefit that fades by twelve months — is exactly the kind of detail that gets lost when headlines summarize PRP as simply "effective" or "ineffective." The authors themselves framed the findings as weak efficacy up to six months with debatable clinical relevance, which is a more accurate description than either extreme.^[PubMed]

A broader systematic review of PRP for musculoskeletal injuries found that results and protocols vary by condition, anatomical target, PRP preparation, comparator, and follow-up period. That review supports condition-specific discussion and explicit limits on generalization; it does not establish one universal timeline or injection series for all musculoskeletal problems.^[PubMed]

A separate systematic review and meta-analysis compared single versus multiple PRP injections for knee osteoarthritis. The reviewed trials included protocols using three injections separated by about one week and assessed outcomes over follow-up periods including 3, 6, and 9 months. Its findings apply to knee osteoarthritis study populations and should not be generalized to every tendon, ligament, joint, diagnosis, or PRP preparation. The evidence supports describing studied schedules and follow-up windows, not promising an individual response date or universal injection count.^[PubMed]

Practical considerations

When you read about PRP, the most useful question is not "does it work?" but "for what, compared with what, and for how long?" The table below summarizes how the supplied research differs across these dimensions so you can see why the answers are not interchangeable.

Limits and responsible use

This article summarizes published research; it cannot tell you whether PRP will help your specific joint, tendon, or ligament problem. Individual results depend on factors a general article cannot assess.

If you are weighing PRP against other options, it may help to compare how PRP and bone marrow aspirate concentrate differ in what they are and how they are studied. You can read more in our guide to PRP vs BMAC comparison. Bring specific questions to a qualified clinician who can review your history and examine the affected area.

Frequently Asked Questions

Is PRP effective?

It depends on the condition and the time frame. In the most recent pooled knee osteoarthritis evidence, pain scores favored PRP over saline placebo at three and six months, but results were highly heterogeneous and no efficacy was found at twelve months. The authors described the evidence as weak efficacy up to six months with debatable clinical relevance.

Why do studies and headlines about PRP seem to disagree?

Studies differ in the condition studied, the anatomical target, how PRP was prepared, what it was compared against, and how long patients were followed. A systematic review of PRP for musculoskeletal injuries found that results and protocols vary across these factors, which is why a finding in one setting does not automatically transfer to another.

What did the most recent pooled PRP research actually measure?

The 2025 review pooled 11 randomized controlled trials with 1,616 participants comparing intra-articular PRP with saline placebo for knee osteoarthritis. It measured pain and function at three, six, and twelve months. Pain favored PRP at three and six months with high heterogeneity; function favored PRP at three months only; no efficacy was found at twelve months.

If PRP helped in one study, does that mean it will help my tendon, ligament, or joint problem?

No. The reviewed evidence applies to its own study populations, preparations, and comparators. The knee osteoarthritis findings should not be generalized to every tendon, ligament, joint, diagnosis, or PRP preparation, and no study can predict an individual response.